Relay Technology Launches Intelligence & Data Visualization Solution
Relay Technology Management recently announced the official launch of Business Development Live (BD Live!) – a new unified, real-time data visualization, comparative asset analysis and tracking platform for the life sciences industry. Relay TM supports life science business development, and licensing professionals validate opportunities and discover new assets.
“BD Live! provides access to a comprehensive information repository on biopharma assets and other relevant entities and utilizes cutting-edge data visualization technologies to create interactive dashboards that dramatically improve the user experience,” said David Greenwald PhD, Relay TM’s Co-founder and Managing Director. “We are excited to open the platform more broadly after having successfully tested our innovative approach with a number of leading pharmaceutical and biotech companies. We look forward to working with customers to fulfill their business intelligence needs.”
“Identifying and evaluating assets, and finding the most appropriate partners for pharmaceutical companies is time-consuming, resource-intensive, and often based on partial information,” shares Peter Collins, Business Intelligence Director at the Nature Publishing Group, which created a collaborative partnership with Relay and made a strategic investment in the company in 2011. “Relay is uniquely positioned to bring much needed objective data aggregation and analysis to speed up the drug development process.”
Relay TM complements competitive intelligence by assessing the relative attractiveness of life science assets – drugs, targets, researchers, and institutions, historically and in real time, from one screen. For more information, visit www.relaytm.com.
Total Page Views: 1001
